For more than 10 years, clinicians have been using fluorescence technology to enhance the visualization of oral mucosa, facilitating the earliest possible discovery of potentially malignant and cancerous lesions. Now, DenMat’s ViziLite PRO has been engineered to operate within the wavelength for optimal discrimination of oral lesions, as defined by years of clinical fluorescence research.
An affordable, handheld device, the ViziLite Pro utilizes powerful shortwave LEDs to generate biofluorescence and enhance visualization. Lack of fluorescence reveals damaged or abnormal cells before they may be noticed visually using a normal clinical exam light.
For more information, call DenMat at (800) 4DENMAT ( 433-6628) or visit denmat.com.